The pharmaceutical industry have seen one of the highest number of transactions in last years, due to the needs of optimisations of the costs of the companies in the sector. One fundamental reason behind the growing costs is the advancement of medicine. To create value, new drugs need either to solve a problem which has previously been intractable, or be significantly better than what already exists on the market. The other driver for the development costs is the ever-increasing regulatory requirements.

We have a long track record in conducting sale and selling processes for companies, products and other assets such as manufacturing sites, as well as financing for expansions. Our Pharmaceutical industry knowledge makes us highly sensitive to the key issues of the sector, allowing us to manage efficiently the operations.